Patrick McIlvenny - Jan 4, 2023 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role
Chief Accounting Officer
Signature
/s/ Adriana Hernandez-Capone, Attorney-in-Fact
Stock symbol
HZNP
Transactions as of
Jan 4, 2023
Transactions value $
-$469,606
Form type
4
Date filed
1/6/2023, 04:56 PM
Previous filing
Nov 14, 2022
Next filing
Oct 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise +7.97K +320.2% 10.5K Jan 5, 2023 Direct F1
transaction HZNP Ordinary Shares Tax liability -$470K -4.15K -39.63% $113.24 6.32K Jan 5, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Restricted Stock Units (RSU) Award $0 +11.5K $0.00 11.5K Jan 4, 2023 Ordinary Shares 11.5K Direct F1, F2
transaction HZNP Restricted Stock Units (RSU) Options Exercise $0 -3.87K -100% $0.00* 0 Jan 5, 2023 Ordinary Shares 3.87K Direct F1, F3
transaction HZNP Restricted Stock Units (RSU) Options Exercise $0 -2.2K -50% $0.00 2.2K Jan 5, 2023 Ordinary Shares 2.2K Direct F1, F4
transaction HZNP Restricted Stock Units (RSU) Options Exercise $0 -1.9K -33.33% $0.00 3.81K Jan 5, 2023 Ordinary Shares 1.9K Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each RSU represents a contingent right to receive one ordinary share of the Issuer.
F2 The RSUs vest 1/3rd annually on each anniversary of January 5, 2023.
F3 The final tranche of ordinary shares subject to the RSU vested on January 5, 2023.
F4 The remaining ordinary shares subject to the RSU vest on January 5, 2024.
F5 The remaining ordinary shares subject to the RSU vest ratably on January 5, 2024 and January 5, 2025